Moran Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Sell
28,615
-1,361
-5% -$90.7K 0.05% 331
2026
Q1
$1.88M Sell
29,976
-164,029
-85% -$11.4M 0.06% 318
2025
Q4
$12.9M Buy
194,005
+40,672
+27% +$2.63M 0.39% 78
2025
Q3
$10.3M Buy
153,333
+125,104
+443% +$9.9M 0.31% 100
2025
Q2
$2.46M Buy
+28,229
New +$2.21M 0.08% 266
2024
Q3
Sell
-3,546
Closed -$402K 413
2024
Q2
$402K Buy
3,546
+1,236
+54% +$156K 0.01% 357
2024
Q1
$320K Buy
+2,310
New +$290K 0.01% 370

Other funds holding DXCM

Moran Wealth Management's DXCM Position: Q2 2026 in Review

Moran Wealth Management reduced its DexCom (DXCM) stake by 4.5% in Q2 2026, selling an estimated $90.7K and leaving 28,615 shares worth $1.93M. The position accounts for 0.05% of the portfolio, ranked #331.

Moran Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 7 quarters since. The position peaked at $12.9M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Moran Wealth Management held 28,615 shares of DexCom worth $1.93M as of Q2 2026.
  • Moran Wealth Management sold 1,361 DexCom shares in Q2 2026, an estimated $90.7K.
  • DexCom made up 0.05% of Moran Wealth Management's portfolio in Q2 2026, its #331 holding.
  • Moran Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 7 quarters since.
  • Moran Wealth Management's DexCom position peaked at $12.9M in Q4 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.